Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Medical Transdermal Patch Market Research Report 2025

Global Medical Transdermal Patch Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 102 Pages

Report ld: 3489284

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Medical Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Medical Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Transdermal Patch.

The Medical Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medical Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grunenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Segment by Type

Methyl Salicylate-based Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Segment by Application

Rx Channel

OTC Channel

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Medical Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Medical Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Medical Transdermal Patch Market Overview

1.1 Product Definition

1.2 Medical Transdermal Patch by Type

1.2.1 Global Medical Transdermal Patch Market Value Comparison by Type (2024 VS 2031)

1.2.2 Methyl Salicylate-based Patch

1.2.3 Diclofenac Patch

1.2.4 Nicotine Transdermal Patch

1.2.5 Others

1.3 Medical Transdermal Patch by Application

1.3.1 Global Medical Transdermal Patch Market Value by Application (2024 VS 2031)

1.3.2 Rx Channel

1.3.3 OTC Channel

1.4 Global Medical Transdermal Patch Market Size Estimates and Forecasts

1.4.1 Global Medical Transdermal Patch Revenue 2020-2031

1.4.2 Global Medical Transdermal Patch Sales 2020-2031

1.4.3 Global Medical Transdermal Patch Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Medical Transdermal Patch Market Competition by Manufacturers

2.1 Global Medical Transdermal Patch Sales Market Share by Manufacturers (2020-2025)

2.2 Global Medical Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Medical Transdermal Patch Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Medical Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application

2.7 Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry

2.8 Global Medical Transdermal Patch Market Competitive Situation and Trends

2.8.1 Global Medical Transdermal Patch Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Medical Transdermal Patch Players Market Share by Revenue

2.8.3 Global Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Medical Transdermal Patch Market Scenario by Region

3.1 Global Medical Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Medical Transdermal Patch Sales by Region: 2020-2031

3.2.1 Global Medical Transdermal Patch Sales by Region: 2020-2025

3.2.2 Global Medical Transdermal Patch Sales by Region: 2026-2031

3.3 Global Medical Transdermal Patch Revenue by Region: 2020-2031

3.3.1 Global Medical Transdermal Patch Revenue by Region: 2020-2025

3.3.2 Global Medical Transdermal Patch Revenue by Region: 2026-2031

3.4 North America Medical Transdermal Patch Market Facts & Figures by Country

3.4.1 North America Medical Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Medical Transdermal Patch Sales by Country (2020-2031)

3.4.3 North America Medical Transdermal Patch Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Medical Transdermal Patch Market Facts & Figures by Country

3.5.1 Europe Medical Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Medical Transdermal Patch Sales by Country (2020-2031)

3.5.3 Europe Medical Transdermal Patch Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Medical Transdermal Patch Market Facts & Figures by Region

3.6.1 Asia Pacific Medical Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Medical Transdermal Patch Sales by Region (2020-2031)

3.6.3 Asia Pacific Medical Transdermal Patch Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Medical Transdermal Patch Market Facts & Figures by Country

3.7.1 Latin America Medical Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Medical Transdermal Patch Sales by Country (2020-2031)

3.7.3 Latin America Medical Transdermal Patch Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Medical Transdermal Patch Market Facts & Figures by Country

3.8.1 Middle East and Africa Medical Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Medical Transdermal Patch Sales by Country (2020-2031)

3.8.3 Middle East and Africa Medical Transdermal Patch Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Medical Transdermal Patch Sales by Type (2020-2031)

4.1.1 Global Medical Transdermal Patch Sales by Type (2020-2025)

4.1.2 Global Medical Transdermal Patch Sales by Type (2026-2031)

4.1.3 Global Medical Transdermal Patch Sales Market Share by Type (2020-2031)

4.2 Global Medical Transdermal Patch Revenue by Type (2020-2031)

4.2.1 Global Medical Transdermal Patch Revenue by Type (2020-2025)

4.2.2 Global Medical Transdermal Patch Revenue by Type (2026-2031)

4.2.3 Global Medical Transdermal Patch Revenue Market Share by Type (2020-2031)

4.3 Global Medical Transdermal Patch Price by Type (2020-2031)

5 Segment by Application

5.1 Global Medical Transdermal Patch Sales by Application (2020-2031)

5.1.1 Global Medical Transdermal Patch Sales by Application (2020-2025)

5.1.2 Global Medical Transdermal Patch Sales by Application (2026-2031)

5.1.3 Global Medical Transdermal Patch Sales Market Share by Application (2020-2031)

5.2 Global Medical Transdermal Patch Revenue by Application (2020-2031)

5.2.1 Global Medical Transdermal Patch Revenue by Application (2020-2025)

5.2.2 Global Medical Transdermal Patch Revenue by Application (2026-2031)

5.2.3 Global Medical Transdermal Patch Revenue Market Share by Application (2020-2031)

5.3 Global Medical Transdermal Patch Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Hisamitsu Pharmaceutical

6.1.1 Hisamitsu Pharmaceutical Company Information

6.1.2 Hisamitsu Pharmaceutical Description and Business Overview

6.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Portfolio

6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Company Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson & Johnson Medical Transdermal Patch Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis Medical Transdermal Patch Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 UCB Pharma

6.4.1 UCB Pharma Company Information

6.4.2 UCB Pharma Description and Business Overview

6.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.4.4 UCB Pharma Medical Transdermal Patch Product Portfolio

6.4.5 UCB Pharma Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Company Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Medical Transdermal Patch Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Teva Pharmaceutical

6.6.1 Teva Pharmaceutical Company Information

6.6.2 Teva Pharmaceutical Description and Business Overview

6.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teva Pharmaceutical Medical Transdermal Patch Product Portfolio

6.6.5 Teva Pharmaceutical Recent Developments/Updates

6.7 Nitto Denko

6.7.1 Nitto Denko Company Information

6.7.2 Nitto Denko Description and Business Overview

6.7.3 Nitto Denko Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nitto Denko Medical Transdermal Patch Product Portfolio

6.7.5 Nitto Denko Recent Developments/Updates

6.8 Grunenthal

6.8.1 Grunenthal Company Information

6.8.2 Grunenthal Description and Business Overview

6.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Grunenthal Medical Transdermal Patch Product Portfolio

6.8.5 Grunenthal Recent Developments/Updates

6.9 IBSA Group

6.9.1 IBSA Group Company Information

6.9.2 IBSA Group Description and Business Overview

6.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.9.4 IBSA Group Medical Transdermal Patch Product Portfolio

6.9.5 IBSA Group Recent Developments/Updates

6.10 GSK

6.10.1 GSK Company Information

6.10.2 GSK Description and Business Overview

6.10.3 GSK Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.10.4 GSK Medical Transdermal Patch Product Portfolio

6.10.5 GSK Recent Developments/Updates

6.11 Luye Pharma Group

6.11.1 Luye Pharma Group Company Information

6.11.2 Luye Pharma Group Description and Business Overview

6.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Luye Pharma Group Medical Transdermal Patch Product Portfolio

6.11.5 Luye Pharma Group Recent Developments/Updates

6.12 Pfizer

6.12.1 Pfizer Company Information

6.12.2 Pfizer Description and Business Overview

6.12.3 Pfizer Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Pfizer Medical Transdermal Patch Product Portfolio

6.12.5 Pfizer Recent Developments/Updates

6.13 Chattem

6.13.1 Chattem Company Information

6.13.2 Chattem Description and Business Overview

6.13.3 Chattem Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Chattem Medical Transdermal Patch Product Portfolio

6.13.5 Chattem Recent Developments/Updates

6.14 Bayer

6.14.1 Bayer Company Information

6.14.2 Bayer Description and Business Overview

6.14.3 Bayer Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Bayer Medical Transdermal Patch Product Portfolio

6.14.5 Bayer Recent Developments/Updates

6.15 Mundipharma

6.15.1 Mundipharma Company Information

6.15.2 Mundipharma Description and Business Overview

6.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Mundipharma Medical Transdermal Patch Product Portfolio

6.15.5 Mundipharma Recent Developments/Updates

6.16 Endo International

6.16.1 Endo International Company Information

6.16.2 Endo International Description and Business Overview

6.16.3 Endo International Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Endo International Medical Transdermal Patch Product Portfolio

6.16.5 Endo International Recent Developments/Updates

6.17 Beijing Tide Pharmaceutical

6.17.1 Beijing Tide Pharmaceutical Company Information

6.17.2 Beijing Tide Pharmaceutical Description and Business Overview

6.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Product Portfolio

6.17.5 Beijing Tide Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Medical Transdermal Patch Industry Chain Analysis

7.2 Medical Transdermal Patch Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Medical Transdermal Patch Production Mode & Process Analysis

7.4 Medical Transdermal Patch Sales and Marketing

7.4.1 Medical Transdermal Patch Sales Channels

7.4.2 Medical Transdermal Patch Distributors

7.5 Medical Transdermal Patch Customer Analysis

8 Medical Transdermal Patch Market Dynamics

8.1 Medical Transdermal Patch Industry Trends

8.2 Medical Transdermal Patch Market Drivers

8.3 Medical Transdermal Patch Market Challenges

8.4 Medical Transdermal Patch Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Medical Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Medical Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Medical Transdermal Patch Market Competitive Situation by Manufacturers in 2024

Table 4. Global Medical Transdermal Patch Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Medical Transdermal Patch Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Medical Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Medical Transdermal Patch Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Medical Transdermal Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Medical Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application

Table 12. Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Medical Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Medical Transdermal Patch Sales by Region (2020-2025) & (K Units)

Table 18. Global Medical Transdermal Patch Sales Market Share by Region (2020-2025)

Table 19. Global Medical Transdermal Patch Sales by Region (2026-2031) & (K Units)

Table 20. Global Medical Transdermal Patch Sales Market Share by Region (2026-2031)

Table 21. Global Medical Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Medical Transdermal Patch Revenue Market Share by Region (2020-2025)

Table 23. Global Medical Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Medical Transdermal Patch Revenue Market Share by Region (2026-2031)

Table 25. North America Medical Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Medical Transdermal Patch Sales by Country (2020-2025) & (K Units)

Table 27. North America Medical Transdermal Patch Sales by Country (2026-2031) & (K Units)

Table 28. North America Medical Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Medical Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Medical Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Medical Transdermal Patch Sales by Country (2020-2025) & (K Units)

Table 32. Europe Medical Transdermal Patch Sales by Country (2026-2031) & (K Units)

Table 33. Europe Medical Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Medical Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Medical Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Medical Transdermal Patch Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Medical Transdermal Patch Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Medical Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Medical Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Medical Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Medical Transdermal Patch Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Medical Transdermal Patch Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Medical Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Medical Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Medical Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Medical Transdermal Patch Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Medical Transdermal Patch Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Medical Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Medical Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Medical Transdermal Patch Sales (K Units) by Type (2020-2025)

Table 51. Global Medical Transdermal Patch Sales (K Units) by Type (2026-2031)

Table 52. Global Medical Transdermal Patch Sales Market Share by Type (2020-2025)

Table 53. Global Medical Transdermal Patch Sales Market Share by Type (2026-2031)

Table 54. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Medical Transdermal Patch Revenue Market Share by Type (2020-2025)

Table 57. Global Medical Transdermal Patch Revenue Market Share by Type (2026-2031)

Table 58. Global Medical Transdermal Patch Price (US$/Unit) by Type (2020-2025)

Table 59. Global Medical Transdermal Patch Price (US$/Unit) by Type (2026-2031)

Table 60. Global Medical Transdermal Patch Sales (K Units) by Application (2020-2025)

Table 61. Global Medical Transdermal Patch Sales (K Units) by Application (2026-2031)

Table 62. Global Medical Transdermal Patch Sales Market Share by Application (2020-2025)

Table 63. Global Medical Transdermal Patch Sales Market Share by Application (2026-2031)

Table 64. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Medical Transdermal Patch Revenue Market Share by Application (2020-2025)

Table 67. Global Medical Transdermal Patch Revenue Market Share by Application (2026-2031)

Table 68. Global Medical Transdermal Patch Price (US$/Unit) by Application (2020-2025)

Table 69. Global Medical Transdermal Patch Price (US$/Unit) by Application (2026-2031)

Table 70. Hisamitsu Pharmaceutical Company Information

Table 71. Hisamitsu Pharmaceutical Description and Business Overview

Table 72. Hisamitsu Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Hisamitsu Pharmaceutical Medical Transdermal Patch Product

Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Medical Transdermal Patch Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Novartis Medical Transdermal Patch Product

Table 84. Novartis Recent Developments/Updates

Table 85. UCB Pharma Company Information

Table 86. UCB Pharma Description and Business Overview

Table 87. UCB Pharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. UCB Pharma Medical Transdermal Patch Product

Table 89. UCB Pharma Recent Developments/Updates

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Medical Transdermal Patch Product

Table 94. Mylan Recent Developments/Updates

Table 95. Teva Pharmaceutical Company Information

Table 96. Teva Pharmaceutical Description and Business Overview

Table 97. Teva Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Teva Pharmaceutical Medical Transdermal Patch Product

Table 99. Teva Pharmaceutical Recent Developments/Updates

Table 100. Nitto Denko Company Information

Table 101. Nitto Denko Description and Business Overview

Table 102. Nitto Denko Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Nitto Denko Medical Transdermal Patch Product

Table 104. Nitto Denko Recent Developments/Updates

Table 105. Grunenthal Company Information

Table 106. Grunenthal Description and Business Overview

Table 107. Grunenthal Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Grunenthal Medical Transdermal Patch Product

Table 109. Grunenthal Recent Developments/Updates

Table 110. IBSA Group Company Information

Table 111. IBSA Group Description and Business Overview

Table 112. IBSA Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. IBSA Group Medical Transdermal Patch Product

Table 114. IBSA Group Recent Developments/Updates

Table 115. GSK Company Information

Table 116. GSK Description and Business Overview

Table 117. GSK Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. GSK Medical Transdermal Patch Product

Table 119. GSK Recent Developments/Updates

Table 120. Luye Pharma Group Company Information

Table 121. Luye Pharma Group Description and Business Overview

Table 122. Luye Pharma Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Luye Pharma Group Medical Transdermal Patch Product

Table 124. Luye Pharma Group Recent Developments/Updates

Table 125. Pfizer Company Information

Table 126. Pfizer Description and Business Overview

Table 127. Pfizer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Pfizer Medical Transdermal Patch Product

Table 129. Pfizer Recent Developments/Updates

Table 130. Chattem Company Information

Table 131. Chattem Description and Business Overview

Table 132. Chattem Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Chattem Medical Transdermal Patch Product

Table 134. Chattem Recent Developments/Updates

Table 135. Bayer Company Information

Table 136. Bayer Description and Business Overview

Table 137. Bayer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Bayer Medical Transdermal Patch Product

Table 139. Bayer Recent Developments/Updates

Table 140. Mundipharma Company Information

Table 141. Mundipharma Description and Business Overview

Table 142. Mundipharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Mundipharma Medical Transdermal Patch Product

Table 144. Mundipharma Recent Developments/Updates

Table 145. Endo International Company Information

Table 146. Endo International Description and Business Overview

Table 147. Endo International Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Endo International Medical Transdermal Patch Product

Table 149. Endo International Recent Developments/Updates

Table 150. Beijing Tide Pharmaceutical Company Information

Table 151. Beijing Tide Pharmaceutical Description and Business Overview

Table 152. Beijing Tide Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Beijing Tide Pharmaceutical Medical Transdermal Patch Product

Table 154. Beijing Tide Pharmaceutical Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Medical Transdermal Patch Distributors List

Table 158. Medical Transdermal Patch Customers List

Table 159. Medical Transdermal Patch Market Trends

Table 160. Medical Transdermal Patch Market Drivers

Table 161. Medical Transdermal Patch Market Challenges

Table 162. Medical Transdermal Patch Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Medical Transdermal Patch

Figure 2. Global Medical Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Medical Transdermal Patch Market Share by Type: 2024 & 2031

Figure 4. Methyl Salicylate-based Patch Product Picture

Figure 5. Diclofenac Patch Product Picture

Figure 6. Nicotine Transdermal Patch Product Picture

Figure 7. Others Product Picture

Figure 8. Global Medical Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Medical Transdermal Patch Market Share by Application: 2024 & 2031

Figure 10. Rx Channel

Figure 11. OTC Channel

Figure 12. Global Medical Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Medical Transdermal Patch Market Size (2020-2031) & (US$ Million)

Figure 14. Global Medical Transdermal Patch Sales (2020-2031) & (K Units)

Figure 15. Global Medical Transdermal Patch Average Price (US$/Unit) & (2020-2031)

Figure 16. Medical Transdermal Patch Report Years Considered

Figure 17. Medical Transdermal Patch Sales Share by Manufacturers in 2024

Figure 18. Global Medical Transdermal Patch Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Medical Transdermal Patch Players: Market Share by Revenue in Medical Transdermal Patch in 2024

Figure 20. Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Medical Transdermal Patch Sales Market Share by Country (2020-2031)

Figure 23. North America Medical Transdermal Patch Revenue Market Share by Country (2020-2031)

Figure 24. United States Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Medical Transdermal Patch Sales Market Share by Country (2020-2031)

Figure 27. Europe Medical Transdermal Patch Revenue Market Share by Country (2020-2031)

Figure 28. Germany Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Medical Transdermal Patch Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Medical Transdermal Patch Revenue Market Share by Region (2020-2031)

Figure 35. China Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Medical Transdermal Patch Sales Market Share by Country (2020-2031)

Figure 45. Latin America Medical Transdermal Patch Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Medical Transdermal Patch Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Medical Transdermal Patch Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Medical Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Medical Transdermal Patch by Type (2020-2031)

Figure 55. Global Revenue Market Share of Medical Transdermal Patch by Type (2020-2031)

Figure 56. Global Medical Transdermal Patch Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Medical Transdermal Patch by Application (2020-2031)

Figure 58. Global Revenue Market Share of Medical Transdermal Patch by Application (2020-2031)

Figure 59. Global Medical Transdermal Patch Price (US$/Unit) by Application (2020-2031)

Figure 60. Medical Transdermal Patch Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Medical Transdermal Patch market? zhanKai

The top companies in the global Medical Transdermal Patch market are Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis.

Related Reports

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 151
USD 3950.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 130
USD 2900.00
(Single User License)
Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical Transdermal Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 173
USD 4900.00
(Single User License)
Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 144
USD 3950.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published Date: 2024-02-07
Pages: 105
USD 2900.00
(Single User License)

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 151
USD 3950.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 130
USD 2900.00 (Single User License)
Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical Transdermal Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
USD 4250.00 (Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 173
USD 4900.00 (Single User License)
Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 144
USD 3950.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published: 2024-02-07
Pages: 105
USD 2900.00 (Single User License)